TrialAsian Pacific journal of cancer prevention : APJCP2022

Triplet (FOLFOXIRI) Versus Doublet (FOLFOX or FOLFIRI) Regimen as First Line Treatment in Metastatic Colorectal Carcinoma, a Prospective Phase II, Randomized Controlled Trial.

Khaled Ahmed Khalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.